TrialMelanoma research2020

A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma.

Jane Mattei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.